Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Pfizer Inc. today announced positive results from the pivotal Phase 3 EV-303 clinical trial (also known as ...
India must treat adolescence as its ’second window of growth’ and invest urgently in nutrition, education and healthy food systems to avert a future health ...
"Our vision was very clear that women's health is inseparable from empowerment. To strengthen women's financial ability, we have launched the Women's Economic Empowerment program, helping them to earn ...
BRAFTOVI + MEKTOVI continued to show a substantial median overall survival benefit of 47.6 months in treatment-naïve patients with BRAF V600E-mutant metastatic non-small cell lung cancer after ...
Gilead Sciences, Inc. (Nasdaq: GILD) today shared positive data from the Phase 3 ASCENT-03 study demonstrating a highly statistically significant and clinically meaningful improvement in ...
The Punch on MSN
Pregnant women cling to multiple micronutrient supplements as malnutrition escalates
As the high cost of living compounds the burden of malnutrition in Nigeria, the provision of Multiple Micronutrient ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced landmark results demonstrating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback